tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Income Statement

Compare
1,231 Followers

Taysha Gene Therapies Income Statement

Last quarter (Q3 2025), Taysha Gene Therapies's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Taysha Gene Therapies's net income was $-32.73M. See Taysha Gene Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 8.33M$ 15.45M$ 2.50M$ 0.00$ 0.00
Gross Profit
$ 8.33M$ 15.45M$ 15.00K$ 0.00$ -9.00K
Operating Expenses
$ 99.79M$ 87.89M$ 126.04M$ 173.27M$ 42.99M
Depreciation and Amortization
$ 1.25M$ 1.37M$ 2.49M$ 492.00K$ 9.00K
EBITDA
$ -87.95M$ -105.20M$ -159.73M$ -172.60M$ -59.97M
Operating Income
$ -91.46M$ -72.44M$ -126.03M$ -173.27M$ -43.00M
Other Income/Expenses
$ 2.16M$ -39.13M$ -39.99M$ -1.26M$ -17.01M
Pretax Income
$ -89.30M$ -111.57M$ -166.01M$ -174.52M$ -60.01M
Net Income
$ -89.30M$ -111.57M$ -166.01M$ -174.52M$ -43.00M
Per Share Metrics
Basic EPS
$ -0.36$ -0.96$ -3.78$ -4.64$ -3.40
Diluted EPS
$ -0.36$ -0.96$ -3.78$ -4.64$ -3.40
Weighted Average Shares Outstanding
250.13M 116.12M 43.95M 37.65M 17.67M
Weighted Average Shares Outstanding (Diluted)
250.13M 116.12M 43.95M 37.65M 17.67M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History